Type 2 Diabetes
2,497
269
359
1,520
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
352 trials with published results (14%)
Research Maturity
1520 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
111 terminated out of 2497 trials
93.2%
+6.7% vs benchmark
20%
509 trials in Phase 3/4
23%
352 of 1520 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1520 completed trials
Clinical Trials (2497)
Closed Loop Glucose Control in a Simulated ICU Setting
Measurements Before and After Participation in a Health Intervention Programme in Halsnaes Municipality
Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)
Transcutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive Impairment
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Mechanism of SGLT2 Inhibition in the Kidney
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
AIM-MET: AI-Guided Microbiome-Targeted Nutrition for Glycemic Improvement in Type 2 Diabetes
Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension
Multimodal Glucose Prediction in Type 2 Diabetes
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
Enhancing Telemedicine for T2D
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes